相似文献
1
Re: What is next in ALS clinical trials?
Neurology. 2008 Apr 15;70(16):1366; author reply 1366-7. doi: 10.1212/01.wnl.0000316828.96520.19.
2
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Jun;5(2):84-98. doi: 10.1080/14660820410020187.
3
Scientific highlights. 17th International Symposium on ALS/MND Yokohama, Japan, November 30, 2006 through December 2, 2006.
Amyotroph Lateral Scler. 2007 Apr;8(2):121-3. doi: 10.1080/17482960701223865.
4
We have a problem: why have ALS trials been negative?
Amyotroph Lateral Scler. 2007 Oct;8(5):259. doi: 10.1080/17482960701649887.
5
What is next in ALS clinical trials?
Neurology. 2007 Aug 21;69(8):719-20. doi: 10.1212/01.wnl.0000271093.41793.ff.
6
Clinical trials in ALS: measurement and natural history.
Adv Neurol. 1991;56:515-9.
7
Multi-drug therapy in amyotrophic lateral sclerosis: the case for a multi-drug approach.
Muscle Nerve. 2004 Nov;30(5):673-5. doi: 10.1002/mus.20186.
8
Therapeutic trials in ALS.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):6-7. doi: 10.1080/14660820310006643.
9
Re: What is next in ALS clinical trials?
Neurology. 2008 Apr 15;70(16):1365-6; author reply 1365-6. doi: 10.1212/01.wnl.0000313562.69443.63.
Zotero 插件